International Nomenclature of Cosmetic Ingredients

Join KOREA PACK & ICPI WEEK 2022 to Be Held June 14 – 17, KINTEX, Korea!

Retrieved on: 
Monday, March 14, 2022

KOREA PACK and ICPI WEEK (Intl Cosmetic and Pharmaceutical Industry Week), the largest packaging, cosmetic and pharmaceutical exhibition in Korea, will be held at KINTEX from June 14th to 17th as hybrid events hosted by Kyungyon Exhibition Corp.

Key Points: 
  • KOREA PACK and ICPI WEEK (Intl Cosmetic and Pharmaceutical Industry Week), the largest packaging, cosmetic and pharmaceutical exhibition in Korea, will be held at KINTEX from June 14th to 17th as hybrid events hosted by Kyungyon Exhibition Corp.
  • KOREA PACK is distinguished by its unique breadth of products and services and the unparalleled internationality of its exhibitors and visitors alike.
  • With a scale of 1,500 companies and 3,500 booths, 80,000sqm (scheduled), KOREA PACK & ICPI WEEK is the biggest packaging, cosmetic and pharmaceutical B2B exhibition in Korea.
  • A premium online platform of KOREA PACK & ICPI WEEK will be arranged for an active business exchange.

KOREA PACK & ICPI WEEK (Int’l Cosmetic and Pharmaceutical Industry Week) 2022 to Provide O2O Service Connecting Offline Exhibition to the Online Business Platform

Retrieved on: 
Monday, December 13, 2021

KOREA PACK and concurrent event ICPI WEEK (Intl Cosmetic and Pharmaceutical Industry Week) will be held as hybrid events in 2022.

Key Points: 
  • KOREA PACK and concurrent event ICPI WEEK (Intl Cosmetic and Pharmaceutical Industry Week) will be held as hybrid events in 2022.
  • ICPI WEEK, International Cosmetic & Pharmaceutical Industry Week, consists of 6 concurrent events: The 12th Materials Handling & Logistics Exhibition (KOREA MAT), The 17th Cosmetic, Pharmaceutical, Bio Process & Technology Exhibition (COPHEX), Intl Exhibition for Chemical Processing and Fine & Specialty Chemicals (KOREA CHEM), The 12th Korea Pharmaceutical and Bio-Pharma Exhibition (KOREA PHARM & BIO), The 16th Laboratory, Analytical Equipment & Biotechnology Exhibition (KOREA LAB) and The Cosmetic Ingredient & Technology Exhibition (CI KOREA).
  • With a scale of 1,500 companies and 3,500 booths, 80,000sqm (scheduled), KOREA PACK & ICPI WEEK is the biggest packaging, cosmetic and pharmaceutical B2B exhibition in Korea.
  • A premium online platform of KOREA PACK & ICPI WEEK will be arranged for an active business exchange.

ANGUS Chemical Company Launches New Alkalizer For Hair Colorant Systems

Retrieved on: 
Thursday, July 15, 2021

BUFFALO GROVE, Ill., July 15, 2021 /PRNewswire/ -- ANGUS Chemical Company ("ANGUS" or "Company"), a leading global manufacturer and marketer of specialty chemicals for Life Sciences and Industrial markets, today announced the commercial introduction of DL-2AP ULTRA PC (INCI: Aminopropanol), a new alkalizer for hair colorant systems.

Key Points: 
  • BUFFALO GROVE, Ill., July 15, 2021 /PRNewswire/ -- ANGUS Chemical Company ("ANGUS" or "Company"), a leading global manufacturer and marketer of specialty chemicals for Life Sciences and Industrial markets, today announced the commercial introduction of DL-2AP ULTRA PC (INCI: Aminopropanol), a new alkalizer for hair colorant systems.
  • DL-2AP ULTRA PC is the latest addition to ANGUS' portfolio of high-purity ULTRA PC-grade multifunctional amino alcohols for personal care and cosmetics.
  • ANGUS is launching DL-2AP ULTRA PC in response to the fast-growing market demand for alternatives to commonly used alkalizing agents, such as monoethanolamine (MEA) and ammonia.
  • "In laboratory evaluations, permanent hair colorant systems formulated with DL-2AP ULTRA PC showed excellent lifting performance, as well as color deposition and fastness comparable to ammonia and MEA," said Mrunalini Dhamdhere, Global Technical Manager, ANGUS Home and Personal Care.

HeiQ Viroblock Certified as Cosmetic Grade and Bio-based Renewable

Retrieved on: 
Thursday, July 2, 2020

ZURICH, July 2, 2020 /PRNewswire/ --Textile innovator HeiQ's antiviral textile technology, HeiQ Viroblock NPJ03, has been certified as safe and sustainable as all its ingredients are cosmetic grade, bio-based, and recycled.

Key Points: 
  • ZURICH, July 2, 2020 /PRNewswire/ --Textile innovator HeiQ's antiviral textile technology, HeiQ Viroblock NPJ03, has been certified as safe and sustainable as all its ingredients are cosmetic grade, bio-based, and recycled.
  • The HeiQ Viroblock NPJ03 is a formulation that contains a minute amount of recycled silver active ingredient and fatty liposome vesicle components.
  • Furthermore, we are proud that HeiQ Viroblock NPJ03 qualifies as a bio-based renewable product and is 100% made from INCI approved cosmetic ingredients,"says Carlo Centonze, co-founder and Chief Executive Officer of HeiQ Group.
  • HeiQ, Viroblock and HeiQ Viroblock are trademark(s) or registered trademark(s) of HeiQ Materials AG.

HeiQ Viroblock Certified as Cosmetic Grade and Bio-based Renewable

Retrieved on: 
Thursday, July 2, 2020

ZURICH, July 2, 2020 /PRNewswire/ --Textile innovator HeiQ's antiviral textile technology, HeiQ Viroblock NPJ03, has been certified as safe and sustainable as all its ingredients are cosmetic grade, bio-based, and recycled.

Key Points: 
  • ZURICH, July 2, 2020 /PRNewswire/ --Textile innovator HeiQ's antiviral textile technology, HeiQ Viroblock NPJ03, has been certified as safe and sustainable as all its ingredients are cosmetic grade, bio-based, and recycled.
  • The HeiQ Viroblock NPJ03 is a formulation that contains a minute amount of recycled silver active ingredient and fatty liposome vesicle components.
  • Furthermore, we are proud that HeiQ Viroblock NPJ03 qualifies as a bio-based renewable product and is 100% made from INCI approved cosmetic ingredients,"says Carlo Centonze, co-founder and Chief Executive Officer of HeiQ Group.
  • HeiQ, Viroblock and HeiQ Viroblock are trademark(s) or registered trademark(s) of HeiQ Materials AG.

Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Receives Notice of Allowance from USPTO for Trademark of Atopidine™

Retrieved on: 
Thursday, April 9, 2020

Kannalife chose Atopidine as the trademark for Limonenyldihydroxybenzyl Ethoxycarbonyl Azetidine ("LEA"), the International Nomenclature of Cosmetic Ingredient (INCI) assigned name for its patented monotherapeutic compound KLS-13022.

Key Points: 
  • Kannalife chose Atopidine as the trademark for Limonenyldihydroxybenzyl Ethoxycarbonyl Azetidine ("LEA"), the International Nomenclature of Cosmetic Ingredient (INCI) assigned name for its patented monotherapeutic compound KLS-13022.
  • "Kannalife is a leader of research and development in the field of cannabinoid therapeutics," said Medical Marijuana, Inc. CEO Dr. Stuart Titus.
  • In pre-clinical testing, Atopidine was shown to decrease inflammatory cytokine (TNF, Il-1, CXCL5 and IL-8) levels at concentrations 50 times less than toxic levels.
  • Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act.

Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Secures New INCI Name for Its Prospective Anti-Inflammatory and Antioxidant Ingredient Atopidine™

Retrieved on: 
Wednesday, January 8, 2020

TheInternational Cosmetic Ingredient Nomenclature Committee assigned the INCI name "Limonenyldihydroxybenzyl Ethoxycarbonyl Azetidine" ("LEA") to Atopidine, one of Kannalife's leading novel cannabidiol (CBD)-like molecules.

Key Points: 
  • TheInternational Cosmetic Ingredient Nomenclature Committee assigned the INCI name "Limonenyldihydroxybenzyl Ethoxycarbonyl Azetidine" ("LEA") to Atopidine, one of Kannalife's leading novel cannabidiol (CBD)-like molecules.
  • "We believe the INCI name assignment is one of the most important steps forward in the commercialization of Atopidine," said Dean Petkanas, CEO of Kannalife.
  • Medical Marijuana, Inc.'s headquarters is in San Diego, California, and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com .
  • Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act.

Kannalife Secures New INCI Name for its Prospective Anti-Inflammatory and Antioxidant Ingredient Atopidine™

Retrieved on: 
Tuesday, January 7, 2020

The International Cosmetic Ingredient Nomenclature Committee assigned the INCI name "Limonenyldihydroxybenzyl Ethoxycarbonyl Azetidine (LEA) to Atopidine, one of Kannalifes leading novel CBD-like molecules.

Key Points: 
  • The International Cosmetic Ingredient Nomenclature Committee assigned the INCI name "Limonenyldihydroxybenzyl Ethoxycarbonyl Azetidine (LEA) to Atopidine, one of Kannalifes leading novel CBD-like molecules.
  • Current pre-clinical research into Atopidine has shown this molecule to exhibit strong anti-inflammatory and antioxidant potential applicability in addressing a number of consumer skin and personal care needs, said Dean Petkanas, CEO of Kannalife.
  • "We believe the INCI name assignment is one of the most important steps forward in commercialization of Atopidine.
  • Kannalife conducts its research and development efforts at the Pennsylvania Biotechnology Center of Bucks County in Doylestown, PA.
    For more information about Kannalife, Inc., visit www.kannalife.com and visit the Companys Twitter page at @Kannalife.

World Personal Care & Cosmetics Market Outlook to 2023: Balancing Natural & Synthetic Ingredients - Approximately 25-30% of the Market is Made up of Natural Ingredients

Retrieved on: 
Monday, November 25, 2019

This growth insights study examines the debate of natural versus synthetic ingredients in the personal care and cosmetic ingredients market, and discusses how the grey zone of synthetic and natural ingredients is leading to consumer confusion and polarization of ingredient categories.

Key Points: 
  • This growth insights study examines the debate of natural versus synthetic ingredients in the personal care and cosmetic ingredients market, and discusses how the grey zone of synthetic and natural ingredients is leading to consumer confusion and polarization of ingredient categories.
  • Approximately 25-30% of the personal care and cosmetics ingredients market is made up of natural ingredients, while the remaining 70-75% is attributed to synthetic ingredients.
  • While these buzzwords are aimed at convincing consumers of the advantages of natural over synthetic ingredients, they often devalue synthetic ingredients.
  • As for natural ingredients, synthetic ingredients must also be discussed at the molecular and tissue levels, by emphasizing their individual and supportive roles in the efficacy, safety, and sustainability of ingredients.

Balancing Natural & Synthetic Ingredients in the Personal Care & Cosmetics Market (2019-2023) - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 21, 2019

The "Balancing Natural and Synthetic Ingredients in the Personal Care and Cosmetics Market, Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Balancing Natural and Synthetic Ingredients in the Personal Care and Cosmetics Market, Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.
  • This growth insights study examines the debate of natural versus synthetic ingredients in the personal care and cosmetic ingredients market, and discusses how the grey zone of synthetic and natural ingredients is leading to consumer confusion and polarization of ingredient categories.
  • Approximately 25-30% of the personal care and cosmetics ingredients market is made up of natural ingredients, while the remaining 70-75% is attributed to synthetic ingredients.
  • While these buzzwords are aimed at convincing consumers of the advantages of natural over synthetic ingredients, they often devalue synthetic ingredients.